by Michael Doe | Aug 19, 2021 | Free Press Releases
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs Roots Analysis is...
by Michael Doe | Aug 12, 2021 | Free Press Releases
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches, especially from the perspective of large-scale manufacturing Roots Analysis is...
by Michael Doe | Aug 12, 2021 | Free Press Releases
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety Roots Analysis is pleased to announce the publication of...
by Michael Doe | Aug 5, 2021 | Free Press Releases
Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development. Roots Analysis is pleased...
by Michael Doe | Aug 5, 2021 | Free Press Releases
Single-use bioreactors are a revolutionary product of the process optimization efforts of drug manufacturers, offering a highly flexible approach to rapidly produce multiple drugs, while notably reducing downtime between batches and operational costs Roots Analysis...
